Supporting Treatment Adherence for Resilience and Thriving (START): A mHealth Intervention to Improve ART Adherence for HIV-Positive Stimulant-Using Men
Funded by: National Institute on Drug Abuse
Project dates: September 2019 - July 2025
Principal Investigator: Hirshfield, SabinaProject dates: September 2019 - July 2025
Principal Investigator: Carrico A (Contact PI)
Principal Investigator: Horvath K
PROJECT DESCRIPTION
This two-arm randomized clinical trial of a 6-month mHealth intervention, for 350 HIV-positive MSM who use stimulants, sought to improve viral load suppression at 6 months and determine whether any gains were maintained at month 12. If effective, START would be scalable to reach a broader population of HIV+ MSM who use stimulants and may be adapted to clinic- and community-based settings.
Abstract on NIH RePORTER